Asset 1.png

Our Story

Changing the Game

Founded in 2021, using technology discovered at the University of New Mexico, we are developing the first RNA-based diagnostic assay to provide physicians with an optimal therapeutic course of action in treating major depressive disorder. With our innovative and insightful technology, Circular Genomics is leading the research and discovery of cutting-edge circular RNA-based diagnostics and therapeutics. Our incredible team is made of leading neuroscientists and psychiatrists working tirelessly to fill the need of reliable diagnostics in mental health care.